ETF Components for LABU - Direxion Daily S&P Biotech Bull 3X Shares


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
ALPN A 0.03 1.06
CRNX B 2.25 0.77
MRNA C 0.58 0.76
RVMD C 5.38 0.76
BPMC B 1.26 0.75
AMGN B 2.45 0.72
VKTX C 7.60 0.71
TWST B 0.48 0.70
UTHR B 1.08 0.69
NTRA B 1.70 0.69
SRPT C -0.12 0.68
VRTX C 2.08 0.65
ALNY C -0.33 0.65
CERE C 0.17 0.65
TGTX C -1.34 0.65
NBIX C 2.54 0.64
PTCT C 7.95 0.64
GERN C 5.98 0.64
HALO B 4.56 0.64
BIIB C 3.72 0.63
REGN C -0.65 0.63
EXAS F -1.22 0.63
CYTK D 1.92 0.63
DYN D 4.33 0.62
EXEL F 0.62 0.62
ARDX C 0.77 0.62
BMRN F 0.94 0.61
BBIO D 3.52 0.61
INSM D -2.04 0.60
IMVT F 1.48 0.60
KRYS D 2.33 0.59
PCVX D 6.39 0.59
RYTM D -1.93 0.59
IRWD F -1.06 0.58
IDYA D 1.53 0.58
SNDX D 1.29 0.58
IONS F 2.46 0.58
KYMR D 2.42 0.57
DVAX F 0.36 0.57
INCY F 0.00 0.57
DNLI F 5.62 0.57
VCEL B 1.81 0.57
ABBV D 1.36 0.57
BCRX D 18.66 0.56
VERA C 4.45 0.55
CLDX D 1.77 0.55
GILD F -0.95 0.55
IOVA D -0.37 0.54
RARE F 0.37 0.53
ALKS F -1.43 0.53
FOLD F 3.54 0.53
RCKT F 1.20 0.53
SWTX D 5.24 0.53
MDGL D 0.36 0.52
NVAX B -4.30 0.52
NUVL D 5.38 0.51
CPRX C 1.03 0.50
AGIO C 3.05 0.50
PRTA F 8.27 0.49
NTLA F 1.90 0.49
RXRX F -0.40 0.49
ARWR F 9.30 0.48
INBX D 0.67 0.48
KROS D 3.03 0.48
ACAD F 1.75 0.47
ARQT D 13.65 0.46
ACLX F 2.17 0.46
MIRM F 0.77 0.46
KURA C 4.59 0.45
MORF F 6.59 0.45
PTGX C 6.28 0.45
APLS F 1.75 0.44
ALT D 13.43 0.44
AKRO F 3.79 0.43
CRSP F 2.24 0.43
VCYT D 2.30 0.43
MYGN A -2.76 0.42
VRDN F -2.73 0.42
DCPH A 0.04 0.39
XNCR C 4.57 0.38
BEAM F 1.26 0.38
BMEA F 7.03 0.37
COGT C 5.03 0.37
CCCC D 1.83 0.37
MGNX F 5.84 0.36
RCUS F 2.57 0.36
RNA B 2.08 0.36
SRRK D 0.21 0.35
SAGE F -2.34 0.34
ADMA B -0.66 0.33
SANA D 7.79 0.33
CDMO C 0.54 0.31
ARCT F -2.44 0.30
CABA F 13.00 0.30
REPL F 1.49 0.30
FDMT D -0.66 0.29
ETNB F 1.21 0.29
VIR F -0.60 0.29
EDIT F 5.63 0.28
TVTX F 1.49 0.28
ZNTL F 2.61 0.26
CDNA B -3.02 0.26
DAWN C -1.20 0.22
OLMA F -3.15 0.22
MNKD D -1.11 0.22
SMMT B -4.16 0.22
NRIX D 6.35 0.21
RGNX F 2.72 0.21
IRON F 0.06 0.21
RLAY F 6.84 0.21
KNSA C 3.18 0.20
CGEM C 1.29 0.19
FATE D 0.47 0.19
VERV F 0.00 0.18
AVXL F 4.18 0.17
ANAB C 1.35 0.16
ALLO F 0.68 0.15
MDXG D 2.54 0.14
CRBU F 0.00 0.13
ALEC F 6.00 0.10
MRSN F -1.53 0.09
SPRY C -1.11 0.07
VYGR D 1.06 0.07
ORIC F 2.42 0.07
RCEL F -5.96 0.03

Recent News for Direxion Daily S&P Biotech Bull 3X Shares & its Holdings

Date Stock Title
May 16 MDGL John Paulson's Strategic Moves in Q1 2024 Highlight Madrigal Pharmaceuticals' Prominent Role
May 15 AMGN AMGEN TO HOST CONFERENCE CALL FOLLOWING ATS 2024
May 15 ABBV AbbVie, Inc. (ABBV) Bank of America Health Care Conference Call Transcript
May 15 VKTX Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
May 15 VCYT Veracyte to Participate in Upcoming Investor Conferences
May 15 CRSP CRISPR Therapeutics AG (CRSP) BofA Securities 2024 Health Care Conference (Transcript)
May 15 CGEM Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 15 SNDX Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors
May 15 ARCT Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences
May 15 GILD Gilead Sciences, Inc. (GILD) RBC Capital Markets Global Healthcare Conference (Transcript)
May 15 RGNX Evaluating Regenxbio: Insights From 9 Financial Analysts
May 15 NVAX 1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell?
May 15 ARQT Q1 2024 Arcutis Biotherapeutics Inc Earnings Call
May 15 BIIB Eisai projects major growth for Alzheimer's therapy Leqembi
May 15 MRNA Moderna Q1: A Promising Pipeline Is Undervalued
May 15 BIIB Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
May 15 AVXL Anavex Life Sciences (AVXL) Upgraded to Buy: What Does It Mean for the Stock?
May 15 ARQT Arcutis Biotherapeutics surges 22% on Q1 beats
May 15 VKTX Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?
May 15 VRTX Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
The investment seeks daily investment results, of 300% of the performance of the S&P Biotechnology Select Industry Index ("index"). The index is provided by S&P and includes domestic companies from the biotechnology industry. The fund normally creates long positions by investing at least 80% of its assets in the securities that comprise the index and/or financial instruments that provide leveraged and unleveraged exposure to the index. These financial instruments include: swap agreements; options on securities and indices; forward contracts; reverse repurchase agreements; ETFs; and other financial instruments. The fund is non-diversified.
Exchange Traded Fund ETF Exchange Traded Funds Index Fund Biotechnology Leveraged ETF Ultra ETF S&P 500 Index CBOE Repurchase Agreement Forward Contract
Back to the Main LABU Page...